Oseltamivir resistance in an influenza A (H3N2) virus isolated from an immunocompromised patient during the 2014-2015 influenza season in Alberta, Canada

被引:11
作者
Chaudhry, Ahsan [1 ,2 ]
Bastien, Nathalie [3 ]
Li, Yan [3 ]
Scott, Allison [4 ]
Pabbaraju, Kanti [5 ]
Stewart, Douglas [1 ,2 ]
Wong, Sallene [5 ]
Drews, Steven J. [6 ,7 ]
机构
[1] Univ Calgary, Dept Oncol, Calgary, AB, Canada
[2] Univ Calgary, Dept Med, Calgary, AB, Canada
[3] Natl Microbiol Lab, Winnipeg, MB, Canada
[4] Surveillance & Assessment Accountabil & Performan, Edmonton, AB, Canada
[5] ProvLab Alberta Calgary, Calgary, AB, Canada
[6] ProvLab Alberta Edmonton, Edmonton, AB, Canada
[7] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada
关键词
H3N2; influenza; neuraminidase inhibitors; reduced susceptibility; resistance; sequence analysis; NEURAMINIDASE INHIBITORS; SUSCEPTIBILITY; ASSAYS;
D O I
10.1111/irv.12415
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This manuscript describes the identification of an oseltamivir-resistant influenza A (H3N2) virus in a respiratory specimen collected from an immunocompromised patient in Alberta, Canada, during the 2014-2015 influenza season. Following treatment with oseltamivir, neuraminidase (NA) gene sequencing indicated the presence of an R292K mutation. Phenotypic susceptibility testing by the NA-Star assay indicated a highly reduced inhibition by oseltamivir and normal inhibition by zanamivir. The use of zanamivir following identification of the oseltamivir-resistant strain, combined with a partial immune reconstitution, was followed by a suggested decrease in the nasopharyngeal viral load in the nasopharynx and clinical improvement of the patient.
引用
收藏
页码:532 / 535
页数:4
相关论文
共 14 条
[1]   Detection of a Transient R292K Mutation in Influenza A/H3N2 Viruses Shed for Several Weeks by an Immunocompromised Patient [J].
Babady, N. Esther ;
Laplante, Jennifer M. ;
Tang, Yi-Wei ;
St George, Kirsten .
JOURNAL OF CLINICAL MICROBIOLOGY, 2015, 53 (04) :1415-1418
[2]   Multiple Influenza A (H3N2) Mutations Conferring Resistance to Neuraminidase Inhibitors in a Bone Marrow Transplant Recipient [J].
Eshaghi, Alireza ;
Shalhoub, Sarah ;
Rosenfeld, Paul ;
Li, Aimin ;
Higgins, Rachel R. ;
Stogios, Peter J. ;
Savchenko, Alexei ;
Bastien, Nathalie ;
Li, Yan ;
Rotstein, Coleman ;
Gubbaya, Jonathan B. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (12) :7188-7197
[3]   Progressive emergence of an oseltamivir-resistant A (H3N2) virus over two courses of oseltamivir treatment in an immunocompromised paediatric patient [J].
Hurt, Aeron C. ;
Leang, Sook Kwan ;
Tiedemann, Karin ;
Butler, Jeff ;
Mechinaud, Francoise ;
Kelso, Anne ;
Downie, Peter ;
Barr, Ian G. .
INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2013, 7 (06) :904-908
[4]   Assessing the Viral Fitness of Oseltamivir-Resistant Influenza Viruses in Ferrets, Using a Competitive-Mixtures Model [J].
Hurt, Aeron C. ;
Nor'e, Siti Sarah ;
McCaw, James M. ;
Fryer, Helen R. ;
Mosse, Jennifer ;
McLean, Angela R. ;
Barr, Ian G. .
JOURNAL OF VIROLOGY, 2010, 84 (18) :9427-9438
[5]  
Isenberg HD., 1992, Clinical microbiology procedures handbook
[6]  
Little K., 2015, Euro Surveill, V20, P1
[7]   Evaluation of Three Influenza Neuraminidase Inhibition Assays for Use in a Public Health Laboratory Setting During the 2011-2012 Influenza Season [J].
Murtaugh, William ;
Mahaman, Lalla ;
Healey, Benjamin ;
Peters, Heather ;
Anderson, Barbara ;
Tran, Mandy ;
Ziese, Marci ;
Carlos, Maria Paz .
PUBLIC HEALTH REPORTS, 2013, 128 :75-87
[8]   MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells [J].
Oh, Ding Yuan ;
Barr, Ian G. ;
Mosse, Jenny A. ;
Laurie, Karen L. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (07) :2189-2194
[9]   Molecular and phylogenetic analysis of haemagglutinin and neuraminidase sequences from recent human influenza type A (H3N2) viral isolates in Southern Greece [J].
Plakokefalos, ET ;
Markoulatos, P ;
Spyrou, N ;
Bei, TA ;
Vamvakopoulos, NC .
ARCHIVES OF VIROLOGY, 2001, 146 (10) :1899-1918
[10]  
Skowronski D, 2015, EUROSURVEILLANCE, V20, P1, DOI DOI 10.2807/1560-7917.ES.2015.20.43.30047